Duration of empiric antibiotic therapy in granulocytopenic patients with cancer.
D000293:Adolescent; D000328:Adult; D000380:Agranulocytosis / Q000150:complications*; D002228:Carbenicillin / Q000008:administration & dosage*; D002512:Cephalothin / Q000008:administration & dosage*; D002648:Child; D002675:Child, Preschool; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D005260:Female; D005335:Fever of Unknown Origin / Q000188:drug therapy; D005839:Gentamicins / Q000008:administration & dosage*; D006801:Humans; D007223:Infant; D007239:Infections / Q000188:drug therapy*; D007938:Leukemia / Q000150:complications*; D007958:Leukocyte Count; D008297:Male; D009369:Neoplasms / Q000150:complications*; D009504:Neutrophils; D013997:Time Factors
D005839:Gentamicins; D002228:Carbenicillin; D002512:Cephalothin